Articles by Larissa Ku
China office decorating start-up gets Eight Roads backing
InDeco, a Chinese startup that offers one-stop commercial workspace decoration solutions, has raised $20 million in a Series C round led by Eight Roads Ventures.
CICC, GL Ventures join $66m round for Suzhou Ribo Life Science
Chinese drug developer Suzhou Ribo Life Science has raised RMB470 million ($66 million) in an extended Series C round led by China State-owned Capital Venture Capital Fund, CICC Capital and GL Ventures, the VC arm of Hillhouse Capital.
Chinese AI player Intellifusion raises $141m
Forebright Capital, Walden International and state-owned Utrust Fund have led a RMB1 billion ($141 million) pre-IPO round for Chinese artificial intelligence (AI) technology developer Intellifusion.
China's Luckin Coffee reveals $310m in fabricated sales
Luckin Coffee, a PE-backed Chinese coffee shop chain that went public in the US last year, has admitted that RMB2.2 billion ($310 million) worth of sales booked in 2019 were fabricated.
China AI player 4Paradigm closes $230m Series C
4Paradigm, a Chinese artificial intelligence (AI) start-up, has raised about $80 million in an extended Series C round, bringing its valuation to more than $2 billion.
Jumpstarted: Investors target China's EV charging networks
Telaidian’s recent Series A round underlines the opportunities in China’s electric vehicle charging space. While growth seems certain, some industry dynamics have yet to play out
China's Haier raises $134m for industrial internet platform
COSMOPlat, an industrial internet platform developed by Chinese home appliance giant Haier Group, has raised RMB950 million ($134 million) in Series A funding led by the state-owned China Structural Reform Fund.
China's Gaocheng secures $300m for debut US dollar fund
Gaocheng Capital, a China-focused private equity firm established in 2018 following a spin-out from Hillhouse Capital, has closed its first US dollar-denominated fund with $300 million in commitments.
Shanghai CDMO player gets $51m Series A
Zhenge Biotech – a Shanghai-based contract development and manufacturing organization (CDMO) for large molecule drugs – has raised $51 million in Series A funding led by Lyfe Capital.
Chinese expense management specialist secures $42m
China Renaissance has led a RMB300 million ($42 million) extended Series C round for Chinese expense management solution provider Huilianyi. Additional contributions came from existing investors SBCVC, Blue Lake Capital and Z Capital.
Temasek, Tencent lead $300m round for China's MiningLamp
MiningLamp Technology, a Chinese big data company, has raised $300 million Series E led by Temasek Holdings and Tencent Holdings. Kuaishou, a local short-video sharing platform backed by Tencent, also took part in the round.
Chinese smart IT services provider Udesk raises $35m
Udesk, a software-as-a-service (SaaS) provider focused on customer service systems, has raised RMB250 million ($35 million) in an extended Series C round from an undisclosed US hedge fund.
Everest leads Series A for Chinese map provider
Fengxing Zhitu, a subsidiary of Chinese courier company SF Express, has raised a RMB100 million ($14 million) Series A round led by Everest Venture Capital. Oriza Holdings, Maison Capital, and Jade Capital also took part.
GP profile: GTJA Investment Group
Having established itself as a leading player in the renminbi space, China healthcare sector specialist GTJA Investment Group now wants to prove its worth to overseas LPs
Chinese optical semiconductor maker raises $14m
Bosheng Guangdian, a Chinese optical semiconductor maker targeting the smart phone market, has raised RMB100 million ($14 million) from a group featuring Vision Knight Capital.
Chinese cultural education business secures $21m Series B
Qinhan Hutong, a Chinese education provider that offers an art and culture curriculum, has raised RMB150 million ($21 million) in Series B funding from Mingde Chuancheng, a Shanghai-based education and consulting company.
Sequoia invests $171m in Chinese dairy products manufacturer
Sequoia Capital China has invested of RMB1.2 billion ($171 million) in Chinese dairy products manufacturer Junlebao, becoming the largest institutional investor with a 15.26% stake.
Deal focus: Neolix finds its self-driving niche
Unable to achieve the cost-effectiveness of America's driverless grocery delivery services in China, Neolix refocused on transporting meals. Investor Yunqi Partners believes simple solutions mean quicker commercialization
Vision Plus hits $400m first close on third China fund
Vision Plus Capital has completed the first closing on its third US dollar-denominated fund with $400 million in commitments. The vehicle comprises separate venture and growth equity capital pools.
Deal focus: 51CTO's prescient training pivot
Chinese IT platform 51CTO switched from online media to online training five years ago and hasn't looked back. With $20 million in Series C funding, the company wants to sustain its rise
Chinese drug developer RemeGen raises $100m
RemeGen, a Chinese drug developer, has raised a $100 million round led by Lilly Asia Ventures and Lake Bleu Capital.
Chinese insurtech player Insgeek gets $25m Series C
SIG and China Renaissance New Economy Fund have co-led a $25 million Series C round for Insgeek, a Chinese insurance technology specialist.
Everest leads $24m round for China's Cloudwise
Chinese enterprise digital solutions provider Cloudwise has raised $24 million in an extended Series D round led by Everest Venture Capital. Sequoia Capital China, WestSummit Capital, ASG and Koala Fund also participated.
Sequoia leads $30m Series B in Chinese RPA player
Encoo Technology, a Chinese robot process automation (RPA) service provider, has raised a $30 million Series B round led by Sequoia Capital China. GSR Ventures and Future Capital re-upped, while Shenzhen Venture Capital came in as a new investor.